New skin serum passes safety check in small trial
NCT ID NCT07517900
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 2 times
Summary
This completed study tested whether a topical serum containing Mitopure is safe for healthy adults. Forty participants applied the serum repeatedly over two weeks. Researchers checked for skin irritation and asked about product traits. The trial focused only on safety, not on whether the serum improves skin appearance.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Mitopure topical serum
- What this could lead to
- If successful, this could support the development of a safe skin serum for cosmetic use.
- What could go wrong
- This is a small, early safety study in healthy people, not designed to test effectiveness. Results may not apply to people with skin conditions.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
40 people
The number who actually took part.
- Started
-
Apr 2026
- Finished
-
May 2026
- Lead sponsor
-
A company
The lead sponsor is a pharmaceutical, biotech, or medical-device company.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Healthy male and female participants aged 18+. * Participant has signed a written Informed Consent. * Participant must agree to refrain from taking any new medications or herbal supplements during the study, unless permitted by the investigator. * Participant does not have grade of 3 or higher of any skin attribute per the grading scale. * Participant is willing to ONLY use the test article on themselves during the study as instructed and not use other facial serum products. * Participant is willing to attend all study visits and to follow the study instructions and prohibitions. * Participant must agree to refrain from using any new facial serum products, cleansers, laundry detergents, fragrances while participating in this study. Exclusion Criteria: * Participant is pregnant, nursing, or planning to become pregnant (by verbal response only). * Participant has a current skin disease of any type (e.g., eczema, psoriasis, rosacea, atopic dermatitis, vitiligo). * Participant has a known allergy to face serum products, or the ingredients included in the test article. * Participant has a history of malignant disease. * Participant has cuts, scratches, abrasions, rashes, scarring, birthmarks, or tattoos on their face that may interfere with assessments. * Participant has a significant past medical history of hepatic, renal, cardiac, pulmonary, digestive, haematological, neurological, locomotor or psychiatric disease. * Participant has a known sensitivity to the test article, similar materials, or their constituents. * Treatment or medication containing sympathomimetics, antihistamines or corticosteroids in the seven days prior to study start. * Medical condition that may affect study data or participant safety which in the opinion of the Investigator would compromise the safety of the participant or study results. * History of poor cooperation, non-compliance, or unreliability. * Investigator deems the participant an unsuitable candidate for the study.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Healthy adult are added.
Genom att skicka in godkänner du våra Användarvillkor
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
PCR Corp
Manchester, M13 0AF, United Kingdom
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Two estradiol dosing schedules put brain effects to the test
- Can magnetic brain zaps ease the pain of a sleepless body?
- Can poor sleep make you hurt more? study probes Insomnia's link to pain
- Does soreness after exercise disrupt sleep more for people with insomnia?
- Could a fatty meal skew your eye scan?
- Can a week at sea level reset lung pressure for high-altitude dwellers?